Strategies for Pitching to and Retaining Top Clients

Speaker: Kaleana Quibell, VP, Wellbeing & Partnerships, Sequoia

Thursday, May 26, 1:00 to 2:00 PM PT

In 2021, it was estimated that the wellness industry has a market size of $1.5 trillion, with an expected growth rate of 5–10% on an annual basis. For an employer focused on employee benefits and experience, that’s a lot of points solutions to choose from!

In this talk, Kaleana will share data and trends surrounding the 2022 employer benefit and wellbeing solutions market. She will share insights around the top requested services from employers, most common areas of focus, and learnings around what products and strategies have been most successful in this realm.

2022 Industry Trends in Employer Benefits & Wellbeing Solutions

Speaker: Kaleana Quibell, VP, Wellbeing & Partnerships, Sequoia

Thursday, May 26, 1:00 to 2:00 PM PT

In 2021, it was estimated that the wellness industry has a market size of $1.5 trillion, with an expected growth rate of 5–10% on an annual basis. For an employer focused on employee benefits and experience, that’s a lot of points solutions to choose from!

In this talk, Kaleana will share data and trends surrounding the 2022 employer benefit and wellbeing solutions market. She will share insights around the top requested services from employers, most common areas of focus, and learnings around what products and strategies have been most successful in this realm.

Regulatory 101: An Insider’s Perspective on Navigating the FDA Regulations Surrounding Digital Health & Devices

Interested in what makes a product salable and approvable? Interested in an insider’s view on what gets your device approved at FDA? Or how to navigate the regulations and use them to your advantage? How will recent developments to the United States Food and Drug Administration regulations impact your healthtech business? Whether you’re a CEO, entrepreneur, investor, clinician, or a professional in the general industry, join us as Neil Di Spirito gives us an insider’s perspective and breaks down what digital health and device companies should know about FDA regulations.